← Human Trials & Peer-Reviewed Studies
[Effects of a nutritional liquid supplement designed for diabetes mellitus on postprandial glucose and pregnancy outcomes in patients with gestational diabetes mellitus].
Plain-language guide to PMID 24423909 (2013): randomized controlled trial.
Key Facts
- PMID
- 24423909
- Journal
- Zhonghua yi xue za zhi
- Year
- 2013
- Study type
- Randomized Controlled Trial
- Authors
- Yu XY et al. (2 authors)
What This Study Did, in Plain Language
What Was Tested
The paper reports a study, published as a randomized controlled trial.
To explore the effects of nutritional liquid supplement designed for diabetes mellitus on postprandial glucose state and pregnancy outcomes in patients with gestational diabetes mellitus (GDM).
And the Mauchy's test of sphericity was employed to determine the correlation.
Who Took Part
By PubMed's age tags, the people studied were young adults and adults, women only.
A total of 69 cases of pregnant GDM women at Department of Obstetrics & Gynecology, First Affiliated Hospital, Chongqing Medical University from October 2011 to January 2012 were randomized into the intervention and control groups.
How the Study Was Run
The design is described as randomized.
Because people in this study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
But only 31 cases in intervention group finished the study versus 29 cases in control group.
The inter-group differences were analyzed for general clinical profiles before intervention, 2-hour postprandial blood glucose levels and pregnancy outcomes, etc.
The General Linear Model Repeated Measures process was used to analyze the variance of 2-hour postprandial blood glucose data.
What Was Measured
Topics PubMed links to this paper include Blood Glucose, Diabetes, Gestational, Dietary Supplements, Postprandial Period and Pregnancy Outcome.
What This Means in Plain Language
The paper is a randomized study.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2013 (Zhonghua yi xue za zhi), a journal based in China.
More context: all human trials.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.